Osaic Holdings
BDTX icon

Osaic Holdings’s Black Diamond Therapeutics BDTX Stock Holding History

Osaic Holdings’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$888 Sell
480
-377
-44% -$922 ﹤0.01% 7525
2026
Q1 		$1.82K Sell
857
-3
-0.3% -$7 ﹤0.01% 7072
2025
Q4 		$2.09K Sell
860
-84
-9% -$297 ﹤0.01% 7079
2025
Q3 		$2.76K Buy
944
+660
+232% +$1.93K ﹤0.01% 7028
2025
Q2 		$704 Hold
284
– – ﹤0.01% 7270
2025
Q1 		$440 Buy
284
+200
+238% +$419 ﹤0.01% 7019
2024
Q4 		$179 Sell
84
-1,502
-95% -$4.3K ﹤0.01% 7179
2024
Q3 		$6.9K Sell
1,586
-643
-29% -$3.5K ﹤0.01% 6052
2024
Q2 		$10.4K Buy
2,229
+1,661
+292% +$8.92K ﹤0.01% 5766
2024
Q1 		$2.88K Hold
568
– – ﹤0.01% 6324
2023
Q4 		$1.59K Sell
568
-149
-21% -$350 ﹤0.01% 6609
2023
Q3 		$2.06K Sell
717
-1,767
-71% -$6.51K ﹤0.01% 6623
2023
Q2 		$11.8K Sell
2,484
-1,518
-38% -$3.1K ﹤0.01% 5880
2023
Q1 		$6.84K Buy
4,002
+1,220
+44% +$2.8K ﹤0.01% 6192
2022
Q4 		$5K Buy
2,782
+522
+23% +$940 ﹤0.01% 6263
2022
Q3 		$3K Hold
2,260
– – ﹤0.01% 6581
2022
Q2 		$5K Sell
2,260
-1,000
-31% -$2.33K ﹤0.01% 6447
2022
Q1 		$668K Sell
3,260
-127
-4% -$464 ﹤0.01% 2941
2021
Q4 		$18K Buy
3,387
+307
+10% +$2.15K ﹤0.01% 5852
2021
Q3 		$26K Sell
3,080
-200
-6% -$1.98K ﹤0.01% 5578
2021
Q2 		$41K Buy
3,280
+2,650
+421% +$52.4K ﹤0.01% 5181
2021
Q1 		$15K Buy
+630
New +$17K ﹤0.01% 5647

Other funds holding BDTX

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Osaic Holdings's BDTX Position: Q2 2026 in Review

Osaic Holdings reduced its Black Diamond Therapeutics (BDTX) stake by 44% in Q2 2026, selling an estimated $922 and leaving 480 shares worth $888. The position accounts for ﹤0.01% of the portfolio, ranked #7525.

Osaic Holdings first reported a position in BDTX in Q1 2021 and has held it in 22 quarters since. The position peaked at $668K in Q1 2022. 96 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

  • Osaic Holdings held 480 shares of Black Diamond Therapeutics worth $888 as of Q2 2026.
  • Osaic Holdings sold 377 Black Diamond Therapeutics shares in Q2 2026, an estimated $922.
  • Black Diamond Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7525 holding.
  • Osaic Holdings first reported a position in Black Diamond Therapeutics in Q1 2021 and has held it in 22 quarters since.
  • Osaic Holdings's Black Diamond Therapeutics position peaked at $668K in Q1 2022.
  • 96 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.